sulforaphane has been researched along with Depression in 3 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After initial screening, 66 patients with previous history of at least one cardiac intervention and current mild to moderate depression were randomly assigned to two parallel groups receiving either sulforaphane (n = 33) or placebo (n = 33) for six successive weeks." | 9.41 | Efficacy and safety of sulforaphane for treatment of mild to moderate depression in patients with history of cardiac interventions: A randomized, double-blind, placebo-controlled clinical trial. ( Akhondzadeh, S; Ashraf-Ganjouei, A; Bagheri, S; Ghazizadeh-Hashemi, F; Mehrpooya, M; Moradi, K; Noorbala, AA; Shahmansouri, N, 2021) |
| "Depression is one of the most common behavioral and psychological symptoms in people with Alzheimer's disease (AD)." | 1.56 | Sulforaphane Reverses the Amyloid-β Oligomers Induced Depressive-Like Behavior. ( Jia, J; Li, T; Quan, M; Wang, W; Wei, C, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W | 1 |
| Wei, C | 1 |
| Quan, M | 1 |
| Li, T | 1 |
| Jia, J | 1 |
| Ghazizadeh-Hashemi, F | 1 |
| Bagheri, S | 1 |
| Ashraf-Ganjouei, A | 1 |
| Moradi, K | 1 |
| Shahmansouri, N | 1 |
| Mehrpooya, M | 1 |
| Noorbala, AA | 1 |
| Akhondzadeh, S | 1 |
| Zhang, JC | 1 |
| Yao, W | 1 |
| Dong, C | 1 |
| Yang, C | 1 |
| Ren, Q | 1 |
| Ma, M | 1 |
| Han, M | 1 |
| Wu, J | 1 |
| Ushida, Y | 1 |
| Suganuma, H | 1 |
| Hashimoto, K | 1 |
1 trial available for sulforaphane and Depression
| Article | Year |
|---|---|
Efficacy and safety of sulforaphane for treatment of mild to moderate depression in patients with history of cardiac interventions: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Aged; Depression; Double-Blind Method; Female; Humans; Isothiocyanates; Male; Middle Aged; Pe | 2021 |
2 other studies available for sulforaphane and Depression
| Article | Year |
|---|---|
Sulforaphane Reverses the Amyloid-β Oligomers Induced Depressive-Like Behavior.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Brain; Depression; Disease Models, | 2020 |
Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation.
Topics: Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Brassica; Depression; Disease Models, | 2017 |